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Awareness about the importance of shared decision-making (SDM) is widespread, however little 
research has focused on discussions surrounding investigations, despite increasing laboratory 
testing in primary care.  
Aim 
To explore the discussion of blood tests in routine primary care consultations. 
Design and Setting 
Secondary analysis of a sample of 50 video-recorded routine primary care consultations from 22 
GPs across 12 practices, plus linked survey and records data, from the One in a Million archive. 
Method 
A coding scheme was developed using qualitative content analysis to explore discussion of blood 
tests in transcripts of recorded consultations. Codes focused on instigating testing, the extent of 
SDM, and how results were explained. Survey data were used to compare patients’ pre-visit 
expectations with consultation content. Medical records were reviewed to compare tests 
discussed with those ordered. 
Results 
In 36/50 consultations which discussed ordering blood tests, 31% of patients hinted they wanted 
a blood test, however none explicitly asked. Only 11% were offered alternative options. In 81% of 
cases the GP gave some explanation of the indication, but only 17% explained limitations of testing. 
Only 32% of patients were informed about all blood tests ordered. 
Of 23/50 consultations in which results were conveyed, the GP gave no explanation of the results 
in 26% of cases. 57% of patients were only informed of an 'assessment' (e.g. ‘normal’), rather than 
the actual result. 
Conclusion 
A lack of information-giving and SDM exists surrounding ordering tests and conveying results. 
Promoting SDM could reduce unnecessary testing and improve patient-centred care.  
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“The active engagement of patients when fateful health care decisions must be made” has been 
described as the pinnacle of patient-centred care (1). Shared decision-making (SDM) is a process in 
which clinicians and patients work together to make decisions based on clinical evidence and patients’ 
informed preferences, and is appropriate in any healthcare setting in which more than one option is 
available, including the option to do nothing (2). SDM should provide patients with information about 
their options, including benefits, limitations and risks, support patients to articulate what they hope 
to achieve and what they perceive as harm, and ensure there is mutual understanding before agreeing 
any action (3, 4). As with treatment, tests have the potential to cause harm, not least through false 
positives and negatives. As such, the importance of providing accurate information about testing 
should not be overlooked. 
A systematic review of patients’ expectations of investigations and interventions, found patients tend 
to overestimate benefit and underestimate harm (5). Patients have been found to regard reassuring 
results as proof of good health (6).  Perhaps partly due to this, rates of testing continue to increase, 
with an 8.7% annual increase in laboratory testing in UK primary care between 2000 and 2015, and an 
estimated £1.8bn of spending on laboratory tests in primary care in 2015/16 (7). Seizing the 
opportunity to educate patients about the risks and benefits of tests in order to promote realistic 
expectations and SDM, as suggested by Hoffmann et al (5), may aid in reducing unnecessary testing. 
This could lighten the workloads of overstretched GPs (8), who are under increasing pressure to 
reduce costs and improve efficiency (9).  
Sparse research has used naturalistic data to examine discussion of investigations in primary care. 
Existing studies have used audio- and video-recordings to examine negotiations surrounding testing 
and how results are conveyed, however these did not focus on blood tests and were based in the USA  
(10, 11). One UK-based observational study examined video-recorded primary care consultations for 
the degree to which doctors met their patients’ preferences for involvement in decisions, however 
they used a simple standardised tool to rate patient involvement in decision-making and did not focus 
on decisions around testing (12).  
Although there is a growing body of evidence examining the benefits, limitations and implementation 
of SDM, much of this research focuses on treatment decisions rather than investigations. Prior 
research examining the implementation of SDM has used tools such as the OPTION scale (13), or 
surveys relying on patient recall (4, 14). Despite research exploring motivations for investigations (15-
17) and the logistics of conveying results to patients (18), there is scant evidence about what actually 
occurs during consultations, including what discussion precedes the decision to test and how 
subsequent results are discussed, particularly in UK general practice. In the context of rising rates of 
blood testing in primary care, growing awareness of the importance of SDM (4), and the lack of research 
into SDM around testing, it is pertinent to examine the content of consultations in which decisions are 
How this fits in 
There is increasing awareness about the importance of shared decision-making, but most research 
focuses on treatment decisions rather than investigations. This study analysed transcripts of video-
recorded primary care consultations, identifying a lack of information-sharing and shared decision-
making around blood testing. Improvement in this area may reduce unnecessary investigations and 




made about blood tests. This observational study used inductive and deductive qualitative content 
analysis to examine the discussion of blood tests in primary care using an existing archive of video-
recorded UK primary care consultations.  
  
Method 
This study used data previously collected for the ‘One in a Million’ (OiaM) study (19) archived at the 
University of Bristol in accordance with the University’s research data access agreement. OiaM was a 
prospective observational study which created a repository of primary care consultations. 23 GPs from 
12 practices, situated in areas of high and low deprivation, across three clinical commissioning groups 
in the west of England, were recruited to have routine consultations recorded between July 2014 and 
April 2015.  
Of 421 eligible adult patients, 334 consented to participate. 327 consultations were successfully video-
recorded, anonymised, and transcribed verbatim. Pre and post-visit survey data and medical record 
entries linked to the index recordings were also collected. All consultations were coded for problems 
and issues discussed. 300 patients consented for their data to be re-used by other researchers subject 
to further NHS Research Ethics Committee approval. (20) 
 
Sampling 
Of 327 consultations in the archive, 159 consultations had already been coded as containing discussion 
surrounding tests. 168 consultations with no discussion regarding tests were excluded, as were 19 
consultations where participants had not consented for their data to be used in future studies. 
These 159 consultations were screened by JM for type of test discussed, and whether the discussion 
was focused around test ordering or test results (Figure 1). Consultations were excluded if they did 
not discuss blood tests, if the patient was already aware of the test result, or the blood test was not 
ordered by a GP in the practice (e.g. secondary care tests). 16 consultations (10%) were coded 
independently by JW and discrepancies highlighted in 3 cases; these were discussed with RB to reach 
consensus. 
71 consultations were identified as suitable for inclusion in this study (Figure 1). 50 consultations were 
selected for further coding, using stratified sampling to ensure a range of GPs. Of 50 consultations 
analysed, 27 contained discussion surrounding ordering blood tests (‘order’ consultations), 14 
contained discussion of blood test results (‘results’ consultations), and 9 contained both (‘order and 
results’ consultations) (Figure 1). All 12 practices and 22 of 23 GPs in the archive were represented by 
these 50 consultations. Table 1 summarises GP and patient demographics. 
Patient survey data were used to compare patients’ pre-visit expectations for testing with actual 
consultation content. Data on pre-visit expectations of ‘tests or investigations’ was available for 23 
(64%) of 36 consultations from the final sample in which ordering blood tests was discussed. Medical 
record entries were available for 31 (86%) of the 36 consultations in which ordering blood tests was 
discussed; these were reviewed to allow comparison between tests discussed and those ordered by 
GPs. 
 




Qualitative content analysis was chosen as the analytic approach to allow objective and content-
sensitive analysis of the consultations (21). Using NVivo 11, the content of ten consultations was 
initially examined and themes generated were grouped into categories. Based on these content 
categories and previous literature, a coding scheme was developed to allow a combination of 
inductive analysis with categories derived from the data and deductive analysis with categories 
derived from the extant literature (21). 
Codes for ‘order’ consultations focused on who instigated blood testing, information given to patients, 
and the degree of SDM surrounding blood tests. Codes for ‘results’ consultations focused on 
information shared with patients about blood test results. The codes were developed in response to 
the content of the data, so were not restricted to using pre-existing scales.     
50 consultations were coded, with 5 (10%) double-coded by JW; discrepancies were discussed with 
RB and the coding scheme adapted as necessary. The coding scheme was reviewed by an independent 




The results focus firstly on ‘order’ consultations; who instigates blood testing, information-sharing, 
and SDM. We then explore how GPs inform patients about blood test results, and how they promote 
patient understanding.  
 
Who instigates blood testing 
In the 36 ‘order’ consultations (both ‘order’ and ‘order and results’ consultations, hereafter referred 
to as ‘order’ consultations), no patients explicitly requested blood tests, however 11 patients (31%) 
‘hinted’ at wanting a blood test. 5/11 hints came in the form of the patient reporting another doctor 
had suggested a blood test might be beneficial, for example: 
Practice 4, GP 4 (female, partner), Patient 17d (female, age 18-35) 
 “with my GP in London, I was talking about getting maybe tests, to see if there’s something 
wrong kind of hormonally....”  
Of the 23/36 ‘order’ consultations for which patient pre-visit survey data on expectations was 
available, 11 patients (48%) had been expecting one or more ‘tests or investigations’ to be ordered, 
10 (43%) were unsure, and 2 (9%) did not expect any to be ordered. This compares to 62 (32%) patients 
expecting ‘tests or investigations’ of the 193 patients in the OiaM archive for whom pre-visit 
expectations data was available. Of 11 patients expecting one or more ‘tests or investigations’ to be 
ordered, 5 (45%) went on to ‘hint’ at wanting a blood test.  
 
Information-sharing 
In 5 (14%) ‘order’ consultations, the GP used only generic terms such as ‘blood tests’ to describe the 
tests to the patient and gave no further detail. Table 2 describes the number of consultations in which 
there was any use of different referencing practices by the GP; the percentage of consultations which 




for example a generic statement about ‘blood tests’, followed by more specifically naming some of 
the included tests. GPs favoured naming specific tests, such as ‘cholesterol’, over naming groups of 
tests, such as ‘full blood count’, however often at the expense of naming all included tests. 
GPs gave some explanation as to why the test was indicated in 29 (81%) of 36 ‘order’ consultations. 
However, some explanations were very brief, such as: 
Practice 6, GP 8 (female, partner), patient 15h (female, age 18-35) 
GP: Is there anything else you wanted to talk about today? 
Pat: Just too much headache. 
GP: Okay, and that can often be linked to low Vitamin D as well. 
 
Other explanations were more thorough: 
Practice 7, GP 10 (male, partner), patient 12j (male, age 36-60) 
“… we might do some bloods, like an MOT. I shouldn't use the term MOT, but for example, 
checking cholesterol level, doing a diabetic check, maybe some simple blood counts, kidney, 
liver. That will give us a good idea of what your cardiovascular risk is, so the risk of a problem 
in the future to your heart or a stroke, and whether we need to do anything about it.”  
 
In only 6 (17%) ‘order’ consultations, did the GP give some explanation of the risks/limitations of the 
tests, such as the risk of false positives or negatives. Examples included the GP informing the patient 
there can be variation between laboratory results, that results of blood tests may be skewed by a 
‘cold’ (in reference to inflammatory markers), and explaining to a patient that inflammatory markers 
are non-specific and cannot determine whether inflammation is in the joints. The most extensive 
discussions about limitations were regarding prostate-specific antigen (PSA) testing. For example:  
Practice 3, GP 5 (male, partner), patient 10e (male, age >60) 
“It can lead to more problems than less problems because as you rightly say, sometimes the 
PSA can be raised and you can have nothing wrong with you. Sometimes, it can be not raised 
and you can still have something wrong with you, in terms of what we’re looking for, which is 
an actual tumour of the prostate. 
……………………………………………………… 
If it comes back as moderately high, the moderate ones are the ones that are the most 
problematic. It probably means you’re okay, but you end up having a biopsy because it’s raised. 
If it’s sky-high, in the hundreds, then we know you’ve got something pretty much wrong with 
you. So it’s the ones in the middle that are so problematic and what we do with it.” 
 
Shared decision-making about blood testing 
In only 4 (11%) ‘order’ consultations, did the GP explicitly offer any alternative option(s), including the 
option of no blood test, or an alternative test e.g. imaging. Of the consultations where more than one 
option was presented, half were regarding testing PSA, the other half were regarding screening for 
arthritis, and all were tests which the patient ‘hinted’ at: 
Practice 5, GP 7 (female, partner), patient 11g (female, age >60) (regarding screening for 
arthritis, which the patient hinted at) 




in the spring with your other blood test.” 
 
Practice 7, GP 10 (male, partner), patient 13j (male, age 36-60) 
 
“… I will give you a leaflet, just regarding the PSA, because I did rush through that, just so you 
can think about it. If, when you come for your bloods, you decide you don't want it, then fine; 
they can take the request off, but it's on there at the moment.” 
 
In 13 (36%) ‘order’ consultations, the patient did not ask any questions about the blood test, nor were 
they offered the opportunity to do so by the GP.  In 18 (50%) consultations, the GP offered the patient 
the opportunity to ask questions, however only twice was this explicit, e.g. “is there anything else you 
want to ask me?”; the remainder were more subtle e.g. “if you are happy doing that?”. 5 patients 
(14%) asked questions about the blood test without being prompted by the GP.   
During 10 (32%) of the 31 ‘order’ consultations in which data was available from the medical record 
regarding which tests were ordered, patients were informed of all tests ordered at least to the level 
of test group or organ. In 16 consultations (52%), additional tests were ordered, beyond those about 
which the patient was informed, and in 5 consultations (16%), the patient was never told more detail 
than just ‘blood tests’ would be ordered.  
 
Informing patients about blood test results 
Of the 23 consultations in which the results of blood tests were discussed (both ‘results’ and ‘order 
and results’ consultations, hereafter referred to as ‘results’ consultations), 8 (35%) were regarding 
entirely normal results, 11 (48%) contained discussion of a new abnormal result, and 4 (17%) 
contained discussion regarding borderline results, those of unclear significance, or an abnormal result 
that was anticipated due to a previously known diagnosis.  
In 13 (57%) ‘results’ consultations, only an assessment of the result was conveyed to the patient (e.g. 
‘high’, ‘low’, ‘normal’), with no numerical detail of the results shared. See Table 3 for further 
breakdown and examples.  
 
Imparting understanding about results 
In 13 (57%) of the 23 ‘results’ consultations, the GP gave no explanation or reminder as to why the 
test was done, and in no consultation did the GP explain any risks/limitations of the test. 
In 6 (26%) ‘results’ consultations, the GP gave no explanation of what the result meant for the patient 
(e.g. aetiology or diagnosis), beyond a simple assessment (e.g. high, low, normal). See Table 4.  
In 10 (43%) ‘results’ consultations, the patient asked no questions about the result, nor did the GP 
offer the opportunity for the patient to do so. 9 (39%) patients asked questions about the result of the 







Perhaps unsurprisingly we found GPs initiate the majority of blood testing, and there is a lack of 
information-giving and SDM surrounding both ordering tests and conveying results. We identified no 
examples of patients explicitly requesting blood tests, however, patients often hinted at wanting a 
blood test, reflecting previous literature suggesting that patients may preferentially use implicit or 
indirect requests to prompt the doctor to offer an action, rather than explicitly asking, and that 
negotiations between doctors and patients are both complex and subtle (22, 23). 
SDM requires the patient to be given options, yet patients were rarely explicitly offered more than 
one option, including the option not to have a blood test. Arguably every time a blood test is offered, 
the patient should at least be explicitly offered the opportunity to decline. Where options exist, 
information-giving is crucial within SDM as well as mandated by the General Medical Council (24). 
Only a minority of patients were informed about all tests ordered at least to the level of test group or 
organ; this has implications not just for SDM but, more fundamentally, informed consent. It is 
impossible to create a universal standard for how much information is enough information, given 
variable patient health literacy, willingness to engage, and logistical factors such as time, however 
although there was usually some explanation of the indications for testing, explanations were 
inarguably sparse.  
Blood tests are not without risk, namely the possibility of false positives - leading to further 
investigations and associated iatrogenic harms - and false negatives, propagating unjustified 
reassurance. It has been suggested that informing patients about the risks and limitations of tests 
could reduce rates of tests unlikely to confer any benefit (5). Despite this, we found GPs rarely touched 
on the limitations of tests before they were ordered, and never mentioned limitations when conveying 
results. Consultations in which PSA testing was discussed exhibited more thorough explanations of 
limitations and explicit offers of options than most, perhaps due to the National Screening 
Committee’s Prostate Cancer Risk Management Programme promoting informed choices about PSA 
testing, supported by a decision aid (25). It could be argued that PSA is a ‘special case’ as it confers a 
sizeable risk of future unnecessary invasive investigations, so discussion is more important, and by 
nature of it often being a stand-alone test more time is available for this. However, any spurious 
abnormal blood test result could trigger a cascade of invasive investigations and these examples 
indicate that more thorough explanation of blood test limitations is possible in primary care.  
Frequently, patients asked no questions about tests being ordered or results being discussed, nor did 
the GP offer them the opportunity to do so; not only indicating to the patient that their participation 
is not important in the decision-making process but also limiting patient education. Positively, some 
patients felt comfortable asking questions without being prompted, indicating that patients are keen 
to understand and expected more information than was provided. It is likely there are more patients 
with questions, not confident enough to ask.  
It has been suggested that giving patients only a simple assessment of a result (e.g. ‘high’, ‘low’), rather 
than the result itself, is an example of paternalism (11). Despite this, we found the majority of patients 
were given only an assessment, in some cases accompanied by no explanation of what the result 
meant. Giving patients raw results, accompanied by an assessment and explanation, along with 
context and limitations of the test, could allow patients to be more proactive in interpreting results 
and promote patient engagement in monitoring their health (11). Arguably SDM should be employed 
not only in the decision to test but also in the interpretation of the results. For example, where 
difficulties arise in how to proceed with borderline results, patients may express a strong preference 





Strengths and limitations 
We believe this is the first UK study to use naturalistic data to examine discussions of blood tests in 
primary care. It did not rely on doctor or patient recall of consultation content. Where previous studies 
were limited to assessing SDM according to specific scales or surveys such as the OPTION scale (4), we 
were able to adapt our analysis according to what was observed in the consultations. 
Data were limited to that collected for the OiaM archive; the patient ‘pre-visit expectations’ data 
recorded whether patients expected ‘tests or investigations’, not blood tests specifically, and we did 
not have access to laboratory reports of the results being discussed. Therefore we were unable to 
identify discrepancies between actual results and what the patient was told. This study was also 
unable to identify occasions where results were not conveyed to the patient at all, or were conveyed 
by an alternative means; a significant proportion of ‘normal’ results are conveyed over the phone by 
non-medical staff or by text message, and we were unable to explore this with the available data. 
Although GPs and patients were aware they were being filmed at the time of data collection, neither 
party knew the aims of this particular study and are therefore less likely to have altered their 
behaviour in relation to discussion around testing. We were not able to assess reported patient 
understanding or preferences for SDM in blood testing specifically as this data was not collected at 
the time. 
There was an element of subjectivity in some of the codes, such as whether the patient ‘hinted’, 
however the coding scheme minimised this with thorough rules and double-coding to improve 
reliability. Analysis was carried out by JM, a junior doctor, JW, an academic GP, and RB, a qualitative 
researcher, who had their own a priori experiences of blood testing discussions from both clinician 
and patient perspectives, which could influence their reflexivity.  
 
Comparison with existing literature 
Keitz et al (2007) used 200 audio-recordings of primary care consultations in the USA to examine 
modes of negotiation between patients with expectations for tests, medications or referrals and their 
primary care physicians (10). In contrast to our findings that no patients explicitly requested a blood 
test, they found nearly half of patient expectations were expressed by direct patient request and 
patient requests altered the outcome of nearly half of consultations in which they were made (10). 
This may reflect cultural differences between UK and US doctor-patient relationships. Pomerantz et al 
(2004) used a sample of 33 video-recordings of consultations in ambulatory clinics in the USA to 
examine how test results were conveyed to patients, and whether this was paternalistic or promoted 
the patient as an independent expert (11). They identified only four consultations discussing results, 
of which none were blood tests, however noted a spectrum of doctors’ reporting practices, ranging 
from offering patients ‘assessments’ of results (e.g. ‘normal’) only, to sharing numerical results only. 
They suggest that the former is an example of paternalism, and the latter proposes the patient as an 
independent expert. Our results reflect this range of reporting practices, however we identified that 
the majority were informed of an ‘assessment’ only. This supports the findings of Kurhila et al (2019) 
who used 7.5 hours of video-recorded interactions in a Finnish hospital to examine how nurses adapt 
their talk about numerical results depending on the recipient and activity (26). They found nurses tend 
to provide patients with qualitative assessments of numerical results, yet they provide doctors with 
numerical information about results.  
A study of 212 video-recorded primary care consultations in England which examined the degree to 




decisions about investigations were doctor-led, compared to 62% of decisions about referrals or 
procedures, and doctors showed variable ability in adapting the decision-making process to their 
patients’ preferences (12). There is evidence that providing patients with thorough information about 
treatment options and a structured opportunity to discuss their preferences leads to higher patient 
satisfaction, reduced rates of intervention and lower costs (27). Despite this, research suggests that 
SDM is not widely implemented (3), particularly for decisions about investigations (12). This supports 
our results which identify a lack of SDM and information-sharing regarding decisions around blood 
testing.  
 
Implications for research and practice 
This research has identified room for improvement in information-giving and SDM in blood testing in 
primary care. Discussions around PSA testing emerged as an example of more thorough information-
giving and highlighted that SDM for blood tests is possible in primary care. However, implementing 
SDM is not without barriers; in one study, GP consultations lasted 50% longer following interventions 
to improve SDM and risk communication (28). Debate exists about whether SDM is appropriate for all 
decisions, with some arguing it is only appropriate where there are multiple genuine options, and 
some patients may decline to be involved regardless (29). Despite this, when the opportunity for blood 
testing arises, it is appropriate to at least offer the patient information, an opportunity to ask 
questions, and multiple options, even if those options are just whether to test or not. Evidence 
suggests when patients are presented with comprehensive information about risks and benefits of 
treatments they are more inclined to opt for conservative management than doctors (3). A Cochrane 
review found use of decision aids reduced the number of patients choosing PSA screening (30). This 
effect was not seen for most other testing and screening choices, however it suggests promoting SDM 
does not uniformly increase time and spending.  
There is growing awareness of the importance of SDM in treatment decisions, however less research 
exists about SDM for investigations. A study using semi-structured interviews with GPs identified that 
GPs considered ordering investigations to be a biomedical decision that allowed the clinician to display 
their medical authority and were not appropriate for SDM (31). Future research should focus on 
attitudes towards SDM in testing amongst both patients and doctors, as well as exploring time and 
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168 not containing 
discussion of test(s) 
88 consultations 
excluded: 
• 56 did not contain 
discussion of blood 
test i.e. only 
discussed other tests 
e.g. imaging. 
• 3 mentioned a blood 
test the patient 
already knew the 
results of. 
• 1 mentioned only 
that they were 
checking which blood 
tests had previously 
been done. 
• 6 discussed a blood 
test which had been 
ordered by someone 
other than a GP in 
the practice. 
• 19 participants had 
not consented for use 
in future studies 
• 3 consultations were 
found not to contain 
discussion of any test 





• 42 containing 
discussion surrounding 
ordering blood tests 
i.e. ‘order’ 
consultations 
• 16 containing 
discussion of blood 
test results i.e. ‘results’ 
consultations 
• 13 containing 
discussion of both of 
the above i.e. ‘order 
and results’ 
consultations. 
327 consultations in 
OiaM archive 
Of which: 
• Blood tests = 81 
• X-ray = 35 
•Urine = 13 
• Stool = 3 
• Endoscopy = 4 
•Ultrasound scan = 8 
•Other imaging e.g. CT = 22 
• Blood pressure = 32 
•Other = 24 
NB: many contained 
discussion of multiple tests. 
159 containing 
discussion of test(s): 
• 64 discussing 
ordering test(s) 
• 62 discussing test 
results 
• 33 discussing both of 
the above. 
Final 50 consultations (stratified to 
represent 22 of 23 GPs): 
• 27 ‘order’ consultations 
• 14 ‘results’ consultations 
• 9 ‘order and results’ consultations 
For a total of 36 consultations in 
which ordering blood tests was 
discussed and 23 consultations in 
which blood test results were 
discussed. 
 













Table 1: Sample characteristics 
 Number of GPs (22) % 
No. of consultations per GP   
1 3 14 
2 10 45 
3 9 41 
 Number of GPs (22) % 
GP gender   
Male 9 41 
Female 13 59 
Years since GP qualification   
≤5 years 4 18 
6-15 years 5 23 
16-25 years 9 41 
≥26 years 4 18 
GP employment status   
Salaried GP 4 18 
GP partner 18 82 
 Number of patients 
(50) 
% 
Patient gender   
Male 20 40 
Female 30 60 
Patient age   
18-35 years 12 24 
36-60 years 16 32 
>60 years 19 38 
No age data available 3 6 
Patient deprivation quintile   
1st (least deprived) 16 32 
2nd 8 16 
3rd 6 12 
4th 4 8 
5th (most deprived)  16 32 
Patient ethnicity   
Asian / Asian British 2 4 
Black / African / Caribbean / Black British 4 8 
Mixed / multiple ethnic groups 2 4 
Other ethnic group 1 2 
Unknown 1 2 













Table 2: Types of description of blood tests in ‘order’ consultations 
Type of description of 
blood test N (36) % Common examples 
Generic term 34 94 ‘Bloods’, ‘blood test’ 
Names by group 17 47 
‘Kidney function’, ‘your kidneys’, ‘liver 
function’, ‘thyroid test’, ‘full blood count’ 
Specific name 24 67 ‘Cholesterol’, ‘sugar level’, ‘PSA’, ‘vitamin D’ 
Specific by diagnosis 9 25 ‘diabetic check’, ‘coeliac blood test’ 
 
 
Table 3: How result is conveyed to patient 
Code 
N 
(23) % Example 
Numerical result only 1 4 
Practice 5, GP 7 (female, partner), patient 5g 
(female, age 36-60) 
Pat: I've had cholesterol recently, because I 
had it done a year ago and it was slightly 
high, so they asked me to come back in a 
year's time. 
GP: It was 6.4- 
Pat: Yes, so it's gone down. 
GP: -which is the absolute figure, having come 
down from 7.1.  
Assessment only 13 57 
Practice 8, GP 16 (male, partner), patient 8p 
(female, age >60) 
GP: Well, your blood count has dropped quite 
low. You’ve never been as low as this 
before. 
Assessment plus numerical 
result 
5 22 
Practice 2, GP 1 (female, salaried), patient 9a 
(female, age 36-60) 
GP: So that was normal, it was 2.7. 
Pat: Right.  
Multiple results given, using 
a combination of the above.  
4 17 
Practice 2, GP 2 (female, salaried), patient 15b 
(female, age 18-35) 
GP: Thyroid blood test is normal. Your 
haemoglobin is a little low but it has 
improved compared to the last blood 
test. It’s now 112, the last time that it 
was taken was actually 9.4 so was a lot 
lower. The important thing is your iron, 
your iron is quite low. Your iron is 10, in a 








Table 4: Explanation of results 
Code 
N 
(23) % Example 
GP gives no explanation of 
what the result meant for the 
patient (e.g. aetiology or 
diagnosis), beyond a simple 
assessment (e.g. high, low, 
normal). 
6 26 
Practice 5, GP 7 (female, partner), patient 1g 
(female, age >60) 
GP: Because you've had the blood test done 
that I asked for, haven't you? 
Pat: I did, not long ago. 
GP: Which were all normal, and they were 
going to do the flu jab at the same 
time… 
GP gives an explanation of 
some of the results conveyed, 
but not others.  
10 44 
Practice 3, GP 3 (female, partner), patient 1c 
(female, age 36-60) 
GP: […] liver test was normal, and your 
kidney test was good. Your blood sugar 
is fine and your thyroid is alright, so 
you're on the right dose of thyroxine. 
Pat: Right, that's good. 
GP: […] your haemoglobin was just slightly 
lower than it has been. 
[…] 
GP: Well, I think the dilemma always is, is 
your anaemia due to the fact that you 
just don't absorb iron very well? Which 
some people don't, and it sounds like 
that's how you've always been, doesn't 
it? 
Pat: Yes. 
GP: Or is it that you're losing blood from 
somewhere else? So what we 
sometimes do when people have an 
unexplained anaemia is we investigate 
your bowels. 
GP gives some explanation of 
all results mentioned, either 
individually or as a collective. 
(NB: this does not account for 
results which may not have 
been mentioned at all.) 
7 30 
Practice 5, GP 6 (male partner), patient 12f 
(female, >60) 
GP:         So the blood tests all came back as 
normal. So […]  we checked your blood 
count. We checked your kidney and 
liver function. We checked you for 
gluten intolerance and any signs of 
infection and that was all normal. […] 
So we get to the situation where we 








Table 5: Questions asked or offered about results 
Code 
N 
(23) % Example 
No questions offered by GP or 
asked by patient 
10 43 - 
GP explicitly offers patient 
opportunity to ask questions 
about blood test 
1 4 
Practice 2, GP 2 (female, salaried), patient 10b 
(male, age 36-60) 
GP: Your inflammatory marker was really 
raised and then it came down […]. It 
showed that things were starting to 
settle but because it’s not back to 
normal it’s important that we repeat 
that blood test to make sure it goes 
back to baseline and that hasn’t been 
persistently up. […] I will add that to the 
bloods as well. Is there anything else 
you want to ask me? 
GP offers the opportunity to 
ask questions about blood test 
less explicitly 
2 9 
Practice 9, GP 15 (male, partner), patient 1o 
(female, age >60) 
GP: We checked the vitamin D level. 
Technically, this is slightly low, but it's 
certainly an adequate level of vitamin 
D. It doesn't explain your symptoms, 
okay? 
Pat: Right. 
Patient asks questions without 
being prompted 
9 39 
Practice 7, GP 12 (male, partner), patient 5l 
(female, age >60) 
GP: Well, the one we were looking at is this 
one here, called the ALT, it’s a type of 
enzyme which is in your liver, and when 
we looked at it before, in November, it 
was 249, and it came down to 103. 
Now, we’re trying to get it down to 40. 
…………………………………………… 
Pat: Yes. What has caused it to come down? 
GP offers general opportunity 
to ask questions at later time 
1 4 
Practice 2, GP 2 (female, salaried), patient 17b 
(female, age unknown) 
GP: Any further questions? 
 
 
